The company is an innovative biopharmaceutical and vaccine research and development company founded by Dr. Xie Liangzhi, an internationally renowned biopharmaceutical R&D and industrialization expert and expert in the New Drug Creation Project Group. It is committed to developing products with differentiated competitive advantages, providing high-quality and low-cost options for domestic and foreign patients, and establishing a leading biopharmaceutical brand. The company has long been committed to developing biopharmaceuticals with differentiated competitive advantages, focusing on the development and industrialization of biopharmaceutical products in various fields of treatment and prevention, such as malignant tumors, autoimmune diseases, infectious diseases, and genetic diseases. The company's main products are SCT800, SCT400, SCT630, SCT510, SCTV01, SCT-I10A, SCT1000, SCT650C, SCTC21C, etc. SCTB35 SCTB14
No Data
No Data